Home

Recent Articles from Benzinga

Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.

Why Americans Need $2M to Feel 'Wealthy' While Europeans Feel Rich At $500K—The Shocking Reality Behind The Numbersbenzinga.com
Via Benzinga · September 15, 2025
$100 Invested In Citigroup 5 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · September 15, 2025
Ocugen Shares Are Trading Higher Monday: What's Going On?benzinga.com
Ocugen shares are trading higher Monday after the company announced a licensing agreement with Kwangdong Pharmaceutical for the exclusive Korean rights to OCU400.
Via Benzinga · September 15, 2025
Sprott Unearths A Metals ETF That Targets Hidden Gemsbenzinga.com
Sprott launches the Active Metals & Miners ETF (METL), targeting undervalued mining stocks across copper, lithium and uranium.
Via Benzinga · September 15, 2025
Oracle Stock Is Rising Monday: What's Going On?benzinga.com
Oracle shares are trading higher on Monday afternoon. The stock is building on a five-day gain of nearly 25%.
Via Benzinga · September 15, 2025
Behind the Scenes of DoorDash's Latest Options Trendsbenzinga.com
Via Benzinga · September 15, 2025
11 Analysts Assess IonQ: What You Need To Knowbenzinga.com
Via Benzinga · September 15, 2025
Where Under Armour Stands With Analystsbenzinga.com
Via Benzinga · September 15, 2025
Here's How Much You Would Have Made Owning FirstCash Hldgs Stock In The Last 5 Yearsbenzinga.com
Via Benzinga · September 15, 2025
What's Going On With GameStop Stock Today?benzinga.com
Shares of GameStop are trading higher Monday afternoon. The stock is extending a rally that has seen shares gain over 10% in the past five days.
Via Benzinga · September 15, 2025
Actor Wears 'Black Tie Scrubs' At Emmy Awards To Honor Health Care Workers: Why Figs Shares Are Trading Higherbenzinga.com
Health care apparel company Figs may have some new fans and customers after the company partnered with Emmy Award winner Noah Wyle.
Via Benzinga · September 15, 2025
New ETF By RAFI Promises Classic Index Exposure Without The Usual Baggagebenzinga.com
RAUS ETF debuts on Nasdaq, tracking a fundamentals-based index that has outperformed the S&P 500 since 2021.
Via Benzinga · September 15, 2025
Assessing VICI Properties: Insights From 7 Financial Analystsbenzinga.com
Via Benzinga · September 15, 2025
What Does the Market Think About Perrigo?benzinga.com
Via Benzinga · September 15, 2025
P/E Ratio Insights for Full Truck Alliance Cobenzinga.com
Via Benzinga · September 15, 2025
Peering Into Exelixis's Recent Short Interestbenzinga.com
Via Benzinga · September 15, 2025
8 Analysts Assess Ventas: What You Need To Knowbenzinga.com
Via Benzinga · September 15, 2025
Forecasting The Future: 8 Analyst Projections For Builders FirstSourcebenzinga.com
Via Benzinga · September 15, 2025
Is Sherwin-Williams Gaining or Losing Market Support?benzinga.com
Via Benzinga · September 15, 2025
Breaking Down Murphy Oil: 7 Analysts Share Their Viewsbenzinga.com
Via Benzinga · September 15, 2025
If You Invested $1000 In MSCI Stock 10 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · September 15, 2025
Circle Stock Is Trending Monday: What's Going On?benzinga.com
Circle shares are higher Monday as bullish momentum was supported by increased trading volume and positive sector trends.
Via Benzinga · September 15, 2025
This Is What Whales Are Betting On T-Mobile USbenzinga.com
Via Benzinga · September 15, 2025
What Analysts Are Saying About Vital Energy Stockbenzinga.com
Via Benzinga · September 15, 2025
Price Over Earnings Overview: Howmet Aerospacebenzinga.com
Via Benzinga · September 15, 2025
Nvidia's China Crisis Is Deepening—Is Trump To Blame?benzinga.com
Nvidia faces mounting pressure from China's regulators and U.S. policy shifts, testing its resilience in a strategically vital market.
Via Benzinga · September 15, 2025
Options Corner: With The Bears Leaving, Strategy's Current Underperformance Could Spell Opportunitybenzinga.com
While Strategy has encountered turbulence recently, fading short interest suggests that MSTR stock could have an uncontested road higher.
Via Benzinga · September 15, 2025
Oracle 'Will Reshape Industries And Change The World': Gene Munster On What OpenAI Deal Meansbenzinga.com
Gene Munster said AI growth is even earlier than expected and may only be in the first inning, after Oracle's recent backlog update.
Via Benzinga · September 15, 2025
Oklo Stock Hit A New All-Time High Today: What's Going On?benzinga.com
Shares of advanced nuclear technology company Oklo hit a new all-time high. The milestone continues a remarkable upward trend for the stock, which has climbed over 1,300% in the past year.
Via Benzinga · September 15, 2025
Quantum Stock Tracker: IonQ's Higher Price Targets, Rigetti Climbs 30%, Nvidia's New Quantum Investmentsbenzinga.com
Quantum stocks have been on a tear over the past week, moving higher on news and momentum.
Via Benzinga · September 15, 2025
How Is The Market Feeling About AutoZone?benzinga.com
Via Benzinga · September 15, 2025
Is the Market Bullish or Bearish on Piper Sandler?benzinga.com
Via Benzinga · September 15, 2025
'It's Going to be Worth a Thousand Dollars, or Whatever It Is, Five Hundred Bucks.' Dave Ramsey Tells A Couple What To Do After Winning The Lotterybenzinga.com
Via Benzinga · September 15, 2025
Small-Cap Comeback? IWM Tops SPY With Fed Cuts On The Horizonbenzinga.com
Small-cap ETF IWM is outpacing SPY as Fed rate cut bets drive investor rotation. Explore ETF flows, price gains, alternatives to IWM, and more.
Via Benzinga · September 15, 2025
What's Going On With Novo Nordisk Shares Monday?benzinga.com
Novo Nordisk shares are trading higher Monday after the company announced European Union approval for oral semaglutide to reduce cardiovascular death, heart attack and stroke.
Via Benzinga · September 15, 2025
Breaking Down Antero Resources: 10 Analysts Share Their Viewsbenzinga.com
Via Benzinga · September 15, 2025
Essex Property Trust Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)benzinga.com
Via Benzinga · September 15, 2025
Smart Money Is Betting Big In AXP Optionsbenzinga.com
Via Benzinga · September 15, 2025
Demystifying Ovintiv: Insights From 7 Analyst Reviewsbenzinga.com
Via Benzinga · September 15, 2025
What's Driving the Market Sentiment Around Twilio?benzinga.com
Via Benzinga · September 15, 2025
What Analysts Are Saying About Civitas Resources Stockbenzinga.com
Via Benzinga · September 15, 2025
Forecasting The Future: 10 Analyst Projections For Equity Residentialbenzinga.com
Via Benzinga · September 15, 2025
Expert Outlook: NNN REIT Through The Eyes Of 6 Analystsbenzinga.com
Via Benzinga · September 15, 2025
Looking Into Mueller Industries's Recent Short Interestbenzinga.com
Via Benzinga · September 15, 2025
Tesla, Robo.ai, Rambus, Telesat And Other Big Stocks Moving Higher On Mondaybenzinga.com
Via Benzinga · September 15, 2025
Looking Into Ares Management's Recent Short Interestbenzinga.com
Via Benzinga · September 15, 2025
Crude Oil Rises 1%; Manufacturing Activity in New York Falls In Septemberbenzinga.com
Via Benzinga · September 15, 2025
XRP Holds At $3 As First Spot XRP ETF Set To Debut This Weekbenzinga.com
XRP (CRYPTO: XRP) is holding near the $3 level as anticipation builds for the debut of the first-ever spot XRP ETF.
Via Benzinga · September 15, 2025
Opendoor 'Not A Meme Stock'? But It's Been Trading Like A TikTok Trendbenzinga.com
Chairman Keith Rabois says Opendoor is not a meme stock and pushes back on notions that its recent surge is purely sentiment-driven.
Via Benzinga · September 15, 2025
Newmont's Midas Touch: Turning Dirt Into 106% YTD Gold While S&P 500 Settles For Bronzemarkets/com
Newmont Corp. (NEM) surges 106% YTD, outshining tech titans. NEM/SPY ratio doubled, signaling operational leverage.
Via Benzinga · September 15, 2025
Bitcoin To Reach $750,000 In The Next 5 Years, Pantera Capital's Dan Morehead Saysbenzinga.com
Pantera Capital founder Dan Morehead on Monday announced plans for a Solana-focused digital asset treasury company to be listed on Nasdaq as he expects the structural Bitcoin (CRYPTO: BTC) bull market to stay intact.
Via Benzinga · September 15, 2025
Why NanoVibronix (NAOV) Stock Is Skyrocketing Todaybenzinga.com
NanoVibronix shares are trading sharply higher on Monday. The company announced a new U.S. patent granted to its wholly-owned subsidiary, ENvue Medical Holdings.
Via Benzinga · September 15, 2025
Voyager Technologies Turns International Space Station Into Cloud Computing Hubbenzinga.com
Voyager Technologies, Inc. (NASDAQ: VOYG) deploys Space Edge™ to the ISS, creating the first multi-cloud region in orbit. System aims to transform real-time data processing, boost security and cut costs for defense, government, and commercial missions.
Via Benzinga · September 15, 2025
Armani's Fashionable Exit: Can Heirs Turn Couture Into Cash For Investors?benzinga.com
Armani's heirs considering public sale of fashion giant could signal luxury market trends, impacting TPR, CPRI, LVMH, Kering, Farfetch and Revolve.
Via Benzinga · September 15, 2025
ETFs Never Had It So Good — The Trillion-Dollar Moment Is Almost Herebenzinga.com
ETF flows are reshaping how Fed policy hits markets. With rate cuts expected, investors eye funds like TLT and LQD for rate-sensitive exposure.
Via Benzinga · September 15, 2025
Looking At Capital One Finl's Recent Unusual Options Activitybenzinga.com
Via Benzinga · September 15, 2025
Expert Outlook: Northern Oil & Gas Through The Eyes Of 7 Analystsbenzinga.com
Via Benzinga · September 15, 2025
Forecasting The Future: 10 Analyst Projections For Extra Space Storagebenzinga.com
Via Benzinga · September 15, 2025
Forecasting The Future: 18 Analyst Projections For Estee Lauder Cosbenzinga.com
Via Benzinga · September 15, 2025
Mid-America Apartment Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)benzinga.com
Via Benzinga · September 15, 2025
Looking Into Norfolk Southern's Recent Short Interestbenzinga.com
Via Benzinga · September 15, 2025
Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analystbenzinga.com
Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining a Buy rating and $30 price target.
Via Benzinga · September 15, 2025
Demystifying Macerich: Insights From 4 Analyst Reviewsbenzinga.com
Via Benzinga · September 15, 2025
Price Over Earnings Overview: Central Garden & Petbenzinga.com
Via Benzinga · September 15, 2025
OpenAI Chairman Compares AI To Dot-Com Bubble: 'Some Companies Will Fail And Some Will Succeed'benzinga.com
OpenAI chair and Sierra CEO Bret Taylor argues that companies will benefit from AI growth, and that a potential AI bubble doesn't scare him.
Via Benzinga · September 15, 2025
Bitcoin Gets The Jitters Around $115,000: Up Or Down Ahead Of FOMC Day?benzinga.com
Bitcoin's (CRYPTO: BTC) tapped $116,000 before retracing below $115,000 on Monday, signaling that fresh catalysts may be needed to lift sentiment as weakening metrics signal a potential pullback.
Via Benzinga · September 15, 2025
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skinbenzinga.com
The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data.
Via Benzinga · September 15, 2025
10 Financials Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · September 15, 2025
10 Consumer Discretionary Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · September 15, 2025
10 Information Technology Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · September 15, 2025
Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impactbenzinga.com
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
Via Benzinga · September 15, 2025
Cisco Taps Ryan Reynolds For Keynote At AI-Powered WebexOne Conferencebenzinga.com
Cisco's annual WebexOne event will take place in San Diego from Sept. 28 to Oct. 1, 2025, showcasing AI-driven innovations for employees and customer experiences.
Via Benzinga · September 15, 2025
12 Communication Services Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · September 15, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · September 15, 2025
12 Industrials Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · September 15, 2025